Can Darzalex (daratumumab) therapy interfere with response assessment? (https://www.myeloma.org/videos/can-darzalex-daratumumab-therapy-interfere-response-assessment)
|
In this week’s video, Dr. Brian GM Durie explains how to determine if monoclonal protein spikes in the blood are actually spikes due to daratumumab therapy. BOTTOM LINE: When assessing response, ensure that a monoclonal protein spike is not a dara spike with the proper tests. |
Ask a Question
Please note that Ask Dr. Durie has been discontinued, and it was designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (mailto:[email protected]) (Please do not send email attachments or lab reports.).
Dr. Brian G.M. Durie (1942-2025) was the co-founder of the IMF. He was a Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels.